Stay updated on Alirocumab for Plaque Regression in PAD Clinical Trial
Sign up to get notified when there's something new on the Alirocumab for Plaque Regression in PAD Clinical Trial page.

Latest updates to the Alirocumab for Plaque Regression in PAD Clinical Trial page
- Check6 days agoChange DetectedThe page’s footer revision/version indicator was updated from **Revision: v3.5.2** to **Revision: v3.5.3**.SummaryDifference0.1%

- Check13 days agoChange DetectedAdded Revision: v3.5.2 and removed Revision: v3.5.0 in the study history.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check42 days agoChange DetectedA new page revision entry v3.5.0 was added to the Record History and an older revision v3.4.3 was removed.SummaryDifference0.1%

- Check50 days agoChange DetectedAdded a Revision: v3.4.3 entry and removed Revision: v3.4.2 from the study record history.SummaryDifference0.1%

- Check78 days agoChange DetectedRevision: v3.4.2 added; removal of notices about government funding status and operations are administrative metadata and do not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check85 days agoChange DetectedAdded a general site status notice about government funding and updated the page revision from v3.4.0 to v3.4.1; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

Stay in the know with updates to Alirocumab for Plaque Regression in PAD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Alirocumab for Plaque Regression in PAD Clinical Trial page.